Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...] …
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...] …
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...] …
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...] …
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...] …
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...] …